Society of Family Planning Research Fund Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2017
NCT03635905
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Society of Family Planning Research Fund

Active Ingredients

Drugs in Phase 4 Trials (1)

gabapentin (neurontin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dilatation, Pathologic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1